Australia Markets close in 4 hrs 48 mins

Cochlear Limited (CHEOY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
76.75+1.71 (+2.28%)
At close: 03:50PM EDT

Cochlear Limited

1 University Avenue
Macquarie University
Sydney, NSW 2109
61 2 9428 6555

IndustryMedical Devices
Full-time employees4,500

Key executives

NameTitlePayExercisedYear born
Mr. Diggory William Howitt BE (Hons), MBACEO, MD, Pres & Exec. Director2.69M241.05k1967
Mr. Stuart SayersChief Financial Officer1.02MN/AN/A
Mr. Jan Janssen MSc Elec EngChief Technology Officer1.13M35.04k1965
Mr. Anthony BishopPres of Asia Pacific & Latin America848.36k10.72kN/A
Ms. Lisa AubertPres of North America673.9kN/AN/A
Mr. Richard Brook MBAPres of EMEA1.26M30.64kN/A
Ms. Kristina DevonVP of Investor RelationsN/AN/AN/A
Ms. Jennifer StevensonVP of Corp. Communications & BrandN/AN/AN/A
Mr. Dean PhizackleaSr. VP of Global Strategic MarketingN/AN/AN/A
Ms. Jennifer HornerySr. VP of Global People & CultureN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Corporate governance

Cochlear Limited’s ISS governance QualityScore as of 1 February 2023 is 1. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 6; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.